Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice
Wenqian He, Chi-Jene Chen, Caitlin E. Mullarkey, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 152

Showing 1-25 of 152 citing articles:

Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
Dora Pinto, Young‐Jun Park, Martina Beltramello, et al.
Nature (2020) Vol. 583, Iss. 7815, pp. 290-295
Open Access | Times Cited: 1954
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
Luca Piccoli, Young‐Jun Park, M. Alejandra Tortorici, et al.
Cell (2020) Vol. 183, Iss. 4, pp. 1024-1042.e21
Open Access | Times Cited: 1432
The role of IgG Fc receptors in antibody-dependent enhancement
Stylianos Bournazos, Aaron Gupta, Jeffrey V. Ravetch
Nature reviews. Immunology (2020) Vol. 20, Iss. 10, pp. 633-643
Open Access | Times Cited: 458
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection
Emma S. Winkler, Pavlo Gilchuk, Jinsheng Yu, et al.
Cell (2021) Vol. 184, Iss. 7, pp. 1804-1820.e16
Open Access | Times Cited: 349
A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial
Raffael Nachbagauer, Jodi Feser, Abdollah Naficy, et al.
Nature Medicine (2020) Vol. 27, Iss. 1, pp. 106-114
Open Access | Times Cited: 271
Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease
Elisabeth A. van Erp, Willem Luytjes, Gerben Ferwerda, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 238
Antibody-Dependent Cellular Phagocytosis in Antiviral Immune Responses
Matthew Zirui Tay, Kevin Wiehe, Justin Pollara
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 202
Double-layered protein nanoparticles induce broad protection against divergent influenza A viruses
Lei Deng, Teena Mohan, Timothy Z. Chang, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 169
Cannabis compounds exhibit anti-inflammatory activity in vitro in COVID-19-related inflammation in lung epithelial cells and pro-inflammatory activity in macrophages
Seegehalli M. Anil, Nurit Shalev, A. C. Vinayaka, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 125
Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection
Ali Zhang, Hannah D. Stacey, Michael R. D’Agostino, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 6, pp. 381-396
Open Access | Times Cited: 124
Airway macrophages as the guardians of tissue repair in the lung
Franz Puttur, Lisa G. Gregory, Clare M. Lloyd
Immunology and Cell Biology (2019) Vol. 97, Iss. 3, pp. 246-257
Open Access | Times Cited: 131
Non-neutralizing antibodies elicited by recombinant Lassa–Rabies vaccine are critical for protection against Lassa fever
Tiago Abreu-Mota, Katie R. Hagen, Kurt Cooper, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 118
Human antibodies targeting Zika virus NS1 provide protection against disease in a mouse model
Mark Bailey, James Duehr, Harrison Dulin, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 98
Structural and functional analysis of a potent sarbecovirus neutralizing antibody
Dora Pinto, Yoonseon Park, Martina Beltramello, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 88
Extra-Neutralizing FcR-Mediated Antibody Functions for a Universal Influenza Vaccine
Carolyn M. Boudreau, Galit Alter
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 81
Alveolar and lung interstitial macrophages: Definitions, functions, and roles in lung fibrosis
Ting Shi, Laura Denney, Huazhang An, et al.
Journal of Leukocyte Biology (2020) Vol. 110, Iss. 1, pp. 107-114
Closed Access | Times Cited: 77
Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in Mice
Guha Asthagiri Arunkumar, Andriani Ioannou, Teddy John Wohlbold, et al.
Journal of Virology (2019) Vol. 93, Iss. 6
Open Access | Times Cited: 76
Structural and functional analysis of a potent sarbecovirus neutralizing antibody
Dora Pinto, Young‐Jun Park, Martina Beltramello, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 76
Adenovirus-based vaccines—a platform for pandemic preparedness against emerging viral pathogens
Lynda Coughlan, Eric J. Kremer, Dmitry M. Shayakhmetov
Molecular Therapy (2022) Vol. 30, Iss. 5, pp. 1822-1849
Open Access | Times Cited: 44
Aluminum-based metal–organic framework nanoparticles as pulmonary vaccine adjuvants
Zachary Stillman, Gerald E. Decker, Michael R. Dworzak, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 25
Trained immunity of alveolar macrophages enhances injury resolution via KLF4-MERTK-mediated efferocytosis
Sreeparna Chakraborty, Abhalaxmi Singh, Li Wang, et al.
The Journal of Experimental Medicine (2023) Vol. 220, Iss. 11
Open Access | Times Cited: 23
Optimal therapeutic activity of monoclonal antibodies against chikungunya virus requires Fc-FcγR interaction on monocytes
Julie M. Fox, Vicky Roy, Bronwyn M. Gunn, et al.
Science Immunology (2019) Vol. 4, Iss. 32
Open Access | Times Cited: 73
Effects of Influenza on Alveolar Macrophage Viability Are Dependent on Mouse Genetic Strain
Danielle Califano, Yoichi Furuya, Dennis W. Metzger
The Journal of Immunology (2018) Vol. 201, Iss. 1, pp. 134-144
Open Access | Times Cited: 70
SARS-CoV-2 presented in the air of an intensive care unit (ICU)
Tingxu Jin, Jun Li, Jun Yang, et al.
Sustainable Cities and Society (2020) Vol. 65, pp. 102446-102446
Open Access | Times Cited: 64
The Role of Matrix Protein 2 Ectodomain in the Development of Universal Influenza Vaccines
Xavier Saelens
The Journal of Infectious Diseases (2019) Vol. 219, Iss. Supplement_1, pp. S68-S74
Open Access | Times Cited: 62
Page 1 - Next Page

Scroll to top